Early-onset Alzheimer disease and its variants

MF Mendez - CONTINUUM: Lifelong Learning in Neurology, 2019 - journals.lww.com
PURPOSE OF REVIEW Early-onset Alzheimer disease (AD) is defined as having an age of
onset younger than 65 years. While early-onset AD is often overshadowed by the more …

Early-onset Alzheimer disease

MF Mendez - Neurologic clinics, 2017 - neurologic.theclinics.com
Alzheimer disease (AD) originally meant a disorder of early-onset (EOAD;< 65 years of age)
and did not include older patients with “senile dementia.” In fact, the first patient reported …

[HTML][HTML] A new perspective on Alzheimer's disease as a brain expression of a complex metabolic disorder

B Polis, AO Samson - Alzheimer's Disease [Internet], 2019 - ncbi.nlm.nih.gov
Alzheimer's disease (AD) is an irredeemable chronic neurodegenerative disorder and the
predominant cause of dementia. The disease progression is associated with the deposition …

A genetic variant of the Wnt receptor LRP6 accelerates synapse degeneration during aging and in Alzheimer's disease

ME Jones, J Büchler, T Dufor, E Palomer, S Teo… - Science …, 2023 - science.org
Synapse loss strongly correlates with cognitive decline in Alzheimer's disease (AD), but the
underlying mechanisms are poorly understood. Deficient Wnt signaling contributes to …

Repetitive transcranial magnetic stimulation for apathy in patients with neurodegenerative conditions, cognitive impairment, stroke, and traumatic brain injury: a …

AI Espiritu, T Hara, JK Tolledo, M Blair… - Frontiers in …, 2023 - frontiersin.org
Background We aimed to determine the effects and tolerability of repetitive transcranial
magnetic stimulation (rTMS) on apathy in patients with neurodegenerative conditions, mild …

The combined effects of microglia activation and brain glucose hypometabolism in early-onset Alzheimer's disease

G Tondo, L Iaccarino, SP Caminiti, L Presotto… - Alzheimer's research & …, 2020 - Springer
Abstract Background Early-onset Alzheimer's disease (EOAD) is characterized by young
age of onset (< 65 years), severe neurodegeneration, and rapid disease progression, thus …

[HTML][HTML] Discerning the role of blood brain barrier dysfunction in Alzheimer's disease

QQ Tao, RR Lin, YH Chen, ZY Wu - Aging and Disease, 2022 - ncbi.nlm.nih.gov
Alzheimer's disease (AD) is the most common form of neurodegenerative disease. The
predominant characteristics of AD are the accumulation of amyloid-β (Aβ) and …

Profiling baseline performance on the Longitudinal Early‐Onset Alzheimer's Disease Study (LEADS) cohort near the midpoint of data collection

DB Hammers, A Eloyan, A Taurone… - Alzheimer's & …, 2023 - Wiley Online Library
Abstract Objective The Longitudinal Early‐Onset Alzheimer's Disease Study (LEADS) seeks
to provide comprehensive understanding of early‐onset Alzheimer's disease (EOAD; onset< …

Longitudinal analysis of brain-predicted age in amnestic and non-amnestic sporadic early-onset Alzheimer's disease

M Gautherot, G Kuchcinski, C Bordier… - Frontiers in Aging …, 2021 - frontiersin.org
Objective: Predicted age difference (PAD) is a score computed by subtracting chronological
age from “brain” age, which is estimated using neuroimaging data. The goal of this study …

[HTML][HTML] Болезнь Альцгеймера с ранним началом

АБ Локшина, ДА Гришина… - Неврология …, 2022 - cyberleninka.ru
Болезнь Альцгеймера (БА)-наиболее распространенная причина когнитивных
нарушений у взрослых. Выделяют две основные формы БА: с ранним началом (дебют …